The use of microRNAs (miRNAs) [39] and Prostate-Specific Membrane Antigen (PSMA) [40] are gaining relevance, not only for PCa diagnosis but also for therapeutic purposes. The gene discussed is FOLH1; the disease is posterior cortical atrophy.